Share Price and Basic Stock Data
Last Updated: February 17, 2026, 7:17 pm
| PEG Ratio | 2.04 |
|---|
📊 Last updated
5d ago
Feb 12, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ARCL Organics Ltd operates within the chemicals sector, focusing on organic products. As of the latest market update, the company’s share price stood at ₹242, with a market capitalization of ₹193 Cr. The revenue has shown a consistent upward trajectory, with sales reported at ₹165 Cr for FY 2023, increasing to ₹191 Cr for FY 2024, and projected at ₹251 Cr for FY 2025. This represents a growth of approximately 15.8% year-on-year for FY 2024 and a robust 31.4% increase anticipated for FY 2025. Quarterly sales figures also reflect this growth trend, with the latest reported sales of ₹43.25 Cr in September 2023 and rising to ₹48.33 Cr by December 2023. The operating profit margin (OPM) has been relatively stable, recorded at 13.21% for the latest quarter, indicating efficient cost management amidst rising sales. Overall, ARCL’s performance aligns well with sector trends, suggesting a solid demand for organic chemicals amidst increasing environmental awareness.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 54.1 Cr. | 152 | 437/135 | 58.8 | 392 | 0.07 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,350 Cr. | 9,271 | 14,250/7,772 | 53.2 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 27.2 Cr. | 90.6 | 258/73.0 | 12.2 | 26.9 | 1.10 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 158 Cr. | 197 | 435/163 | 23.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,569.75 Cr | 1,482.27 | 158.98 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.00 | 31.71 | 46.44 | 41.58 | 43.25 | 48.33 | 57.57 | 59.93 | 56.46 | 61.96 | 72.24 | 67.34 | 86.19 |
| Expenses | 36.27 | 30.36 | 40.04 | 38.47 | 39.51 | 41.00 | 52.20 | 54.12 | 51.33 | 58.14 | 63.25 | 60.94 | 74.80 |
| Operating Profit | 4.73 | 1.35 | 6.40 | 3.11 | 3.74 | 7.33 | 5.37 | 5.81 | 5.13 | 3.82 | 8.99 | 6.40 | 11.39 |
| OPM % | 11.54% | 4.26% | 13.78% | 7.48% | 8.65% | 15.17% | 9.33% | 9.69% | 9.09% | 6.17% | 12.44% | 9.50% | 13.21% |
| Other Income | 0.58 | 0.01 | 2.25 | 0.43 | 0.64 | 0.81 | 0.82 | 0.41 | 0.71 | 0.83 | 0.40 | 0.83 | 1.18 |
| Interest | 0.44 | 0.45 | 0.51 | 0.51 | 1.03 | 1.85 | 0.76 | 1.25 | 1.23 | 1.14 | 1.24 | 1.17 | 0.99 |
| Depreciation | 1.00 | 0.64 | 1.30 | 1.33 | 1.29 | 1.17 | 0.50 | 1.37 | 1.13 | 1.29 | 1.42 | 1.39 | 1.49 |
| Profit before tax | 3.87 | 0.27 | 6.84 | 1.70 | 2.06 | 5.12 | 4.93 | 3.60 | 3.48 | 2.22 | 6.73 | 4.67 | 10.09 |
| Tax % | 28.94% | 29.63% | 73.39% | 16.47% | 55.83% | 30.86% | 2.03% | 27.22% | 42.53% | 24.77% | 19.02% | 18.42% | 29.83% |
| Net Profit | 2.76 | 0.19 | 1.81 | 1.42 | 0.91 | 3.53 | 4.83 | 2.62 | 2.01 | 1.67 | 5.46 | 3.81 | 7.08 |
| EPS in Rs | 3.45 | 0.24 | 2.26 | 1.78 | 1.14 | 4.41 | 6.04 | 3.28 | 2.51 | 2.09 | 6.82 | 4.76 | 8.85 |
Last Updated: December 28, 2025, 2:34 am
Below is a detailed analysis of the quarterly data for ARCL Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 86.19 Cr.. The value appears strong and on an upward trend. It has increased from 67.34 Cr. (Jun 2025) to 86.19 Cr., marking an increase of 18.85 Cr..
- For Expenses, as of Sep 2025, the value is 74.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 60.94 Cr. (Jun 2025) to 74.80 Cr., marking an increase of 13.86 Cr..
- For Operating Profit, as of Sep 2025, the value is 11.39 Cr.. The value appears strong and on an upward trend. It has increased from 6.40 Cr. (Jun 2025) to 11.39 Cr., marking an increase of 4.99 Cr..
- For OPM %, as of Sep 2025, the value is 13.21%. The value appears strong and on an upward trend. It has increased from 9.50% (Jun 2025) to 13.21%, marking an increase of 3.71%.
- For Other Income, as of Sep 2025, the value is 1.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.83 Cr. (Jun 2025) to 1.18 Cr., marking an increase of 0.35 Cr..
- For Interest, as of Sep 2025, the value is 0.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.17 Cr. (Jun 2025) to 0.99 Cr., marking a decrease of 0.18 Cr..
- For Depreciation, as of Sep 2025, the value is 1.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.39 Cr. (Jun 2025) to 1.49 Cr., marking an increase of 0.10 Cr..
- For Profit before tax, as of Sep 2025, the value is 10.09 Cr.. The value appears strong and on an upward trend. It has increased from 4.67 Cr. (Jun 2025) to 10.09 Cr., marking an increase of 5.42 Cr..
- For Tax %, as of Sep 2025, the value is 29.83%. The value appears to be increasing, which may not be favorable. It has increased from 18.42% (Jun 2025) to 29.83%, marking an increase of 11.41%.
- For Net Profit, as of Sep 2025, the value is 7.08 Cr.. The value appears strong and on an upward trend. It has increased from 3.81 Cr. (Jun 2025) to 7.08 Cr., marking an increase of 3.27 Cr..
- For EPS in Rs, as of Sep 2025, the value is 8.85. The value appears strong and on an upward trend. It has increased from 4.76 (Jun 2025) to 8.85, marking an increase of 4.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:12 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 71 | 71 | 87 | 141 | 165 | 191 | 251 | 288 |
| Expenses | 46 | 67 | 64 | 74 | 126 | 147 | 171 | 227 | 257 |
| Operating Profit | 2 | 4 | 7 | 12 | 15 | 18 | 20 | 24 | 31 |
| OPM % | 5% | 6% | 10% | 14% | 11% | 11% | 10% | 9% | 11% |
| Other Income | 2 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 3 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 5 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 5 | 6 |
| Profit before tax | 1 | 2 | 3 | 10 | 15 | 17 | 14 | 16 | 24 |
| Tax % | 45% | 26% | 24% | 29% | 29% | 30% | 23% | 27% | |
| Net Profit | 1 | 1 | 3 | 7 | 10 | 12 | 11 | 12 | 18 |
| EPS in Rs | 0.70 | 1.40 | 3.21 | 9.14 | 13.10 | 14.72 | 13.38 | 14.69 | 22.52 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 200.00% | 133.33% | 42.86% | 20.00% | -8.33% | 9.09% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | -66.67% | -90.48% | -22.86% | -28.33% | 17.42% |
ARCL Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 10, 2025, 3:50 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 13 | 14 | 16 | 24 | 34 | 46 | 56 | 68 | 78 |
| Borrowings | 10 | 20 | 17 | 10 | 16 | 20 | 29 | 35 | 42 |
| Other Liabilities | 18 | 15 | 13 | 26 | 35 | 39 | 55 | 50 | 48 |
| Total Liabilities | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 | 176 |
| Fixed Assets | 18 | 21 | 20 | 20 | 26 | 45 | 62 | 67 | 70 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 30 | 35 | 33 | 47 | 66 | 66 | 85 | 93 | 105 |
| Total Assets | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 | 176 |
Below is a detailed analysis of the balance sheet data for ARCL Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 78.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 35.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48.00 Cr.. The value appears to be improving (decreasing). It has decreased from 50.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 15.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 12.00 Cr..
- For Total Assets, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 161.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 15.00 Cr..
Notably, the Reserves (78.00 Cr.) exceed the Borrowings (42.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -16.00 | -10.00 | 2.00 | -1.00 | -2.00 | -9.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 87 | 87 | 96 | 82 | 71 | 65 | 75 |
| Inventory Days | 59 | 35 | 45 | 40 | 43 | 38 | 58 | 28 |
| Days Payable | 102 | 51 | 43 | 89 | 88 | 83 | 110 | 75 |
| Cash Conversion Cycle | 55 | 71 | 89 | 48 | 37 | 25 | 13 | 28 |
| Working Capital Days | 56 | 84 | 32 | 49 | 46 | 31 | 25 | 28 |
| ROCE % | 9% | 15% | 30% | 33% | 28% | 21% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Diluted EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Cash EPS (Rs.) | 21.93 | 19.49 | 17.93 | 14.95 | 11.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Revenue From Operations / Share (Rs.) | 313.24 | 238.40 | 206.32 | 176.58 | 108.34 |
| PBDIT / Share (Rs.) | 32.70 | 27.52 | 26.63 | 22.04 | 18.27 |
| PBIT / Share (Rs.) | 26.19 | 22.15 | 23.30 | 20.25 | 16.42 |
| PBT / Share (Rs.) | 20.94 | 18.31 | 20.87 | 18.56 | 14.03 |
| Net Profit / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| NP After MI And SOA / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| PBDIT Margin (%) | 10.43 | 11.54 | 12.90 | 12.48 | 16.86 |
| PBIT Margin (%) | 8.36 | 9.29 | 11.29 | 11.46 | 15.15 |
| PBT Margin (%) | 6.68 | 7.68 | 10.11 | 10.50 | 12.95 |
| Net Profit Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| NP After MI And SOA Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| Return on Networth / Equity (%) | 15.92 | 17.25 | 21.51 | 24.75 | 24.97 |
| Return on Capital Employeed (%) | 20.80 | 19.94 | 26.46 | 31.05 | 32.01 |
| Return On Assets (%) | 7.30 | 7.18 | 9.70 | 11.13 | 12.83 |
| Long Term Debt / Equity (X) | 0.20 | 0.27 | 0.19 | 0.08 | 0.06 |
| Total Debt / Equity (X) | 0.43 | 0.44 | 0.37 | 0.33 | 0.26 |
| Asset Turnover Ratio (%) | 1.54 | 1.37 | 1.54 | 0.00 | 1.48 |
| Current Ratio (X) | 1.48 | 1.37 | 1.47 | 1.59 | 1.94 |
| Quick Ratio (X) | 1.27 | 1.04 | 1.22 | 1.30 | 1.65 |
| Inventory Turnover Ratio (X) | 13.80 | 7.98 | 9.77 | 0.00 | 9.59 |
| Interest Coverage Ratio (X) | 6.23 | 7.17 | 10.99 | 13.03 | 7.66 |
| Interest Coverage Ratio (Post Tax) (X) | 3.94 | 4.68 | 7.02 | 8.78 | 5.21 |
| Enterprise Value (Cr.) | 198.81 | 48.46 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 0.79 | 0.25 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 7.60 | 2.20 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.37 | 0.52 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.06 | 0.32 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for ARCL Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 21.93. This value is within the healthy range. It has increased from 19.49 (Mar 24) to 21.93, marking an increase of 2.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 313.24. It has increased from 238.40 (Mar 24) to 313.24, marking an increase of 74.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 27.52 (Mar 24) to 32.70, marking an increase of 5.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.19. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 26.19, marking an increase of 4.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 20.94. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 20.94, marking an increase of 2.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For PBDIT Margin (%), as of Mar 25, the value is 10.43. This value is within the healthy range. It has decreased from 11.54 (Mar 24) to 10.43, marking a decrease of 1.11.
- For PBIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 9.29 (Mar 24) to 8.36, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 6.68, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 5. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 15.92, marking a decrease of 1.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.80. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 20.80, marking an increase of 0.86.
- For Return On Assets (%), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.30, marking an increase of 0.12.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.20, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.44 (Mar 24) to 0.43, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has increased from 1.37 (Mar 24) to 1.54, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.48, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.27, marking an increase of 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.80. This value exceeds the healthy maximum of 8. It has increased from 7.98 (Mar 24) to 13.80, marking an increase of 5.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has decreased from 7.17 (Mar 24) to 6.23, marking a decrease of 0.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.94. This value is within the healthy range. It has decreased from 4.68 (Mar 24) to 3.94, marking a decrease of 0.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 198.81. It has increased from 48.46 (Mar 24) to 198.81, marking an increase of 150.35.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.79, marking an increase of 0.54.
- For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 7.60, marking an increase of 5.40.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For Price / BV (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 2.37, marking an increase of 1.85.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.32 (Mar 24) to 0.06, marking a decrease of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ARCL Organics Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.8% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.92% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.4 (Industry average Stock P/E: 158.98)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
ARCL Organics Ltd. is a Public Limited Listed company incorporated on 08/09/1992 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L24121WB1992PLC056562 and registration number is 056562. Currently Company is involved in the business activities of Manufacture of basic chemicals. Company's Total Operating Revenue is Rs. 250.59 Cr. and Equity Capital is Rs. 8.00 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Rampur, P.S. Maheshtala, Budge Budge Trunk Road, Kolkata West Bengal 700141 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Suraj Ratan Mundhra | Chairman & Managing Director |
| Mr. Rajesh Mundhra | Executive Director |
| Mr. Brij Mohan Mohta | Ind. Non-Executive Director |
| Mrs. Stuti Pithisaria | Ind. Non-Executive Director |
| Mr. Prateek Chaudhary | Ind. Non-Executive Director |
| Mr. Mukesh Mundra | Executive Director |
FAQ
What is the intrinsic value of ARCL Organics Ltd?
ARCL Organics Ltd's intrinsic value (as of 17 February 2026) is ₹386.10 which is 95.99% higher the current market price of ₹197.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹158 Cr. market cap, FY2025-2026 high/low of ₹435/163, reserves of ₹78 Cr, and liabilities of ₹176 Cr.
What is the Market Cap of ARCL Organics Ltd?
The Market Cap of ARCL Organics Ltd is 158 Cr..
What is the current Stock Price of ARCL Organics Ltd as on 17 February 2026?
The current stock price of ARCL Organics Ltd as on 17 February 2026 is ₹197.
What is the High / Low of ARCL Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ARCL Organics Ltd stocks is ₹435/163.
What is the Stock P/E of ARCL Organics Ltd?
The Stock P/E of ARCL Organics Ltd is 23.4.
What is the Book Value of ARCL Organics Ltd?
The Book Value of ARCL Organics Ltd is 108.
What is the Dividend Yield of ARCL Organics Ltd?
The Dividend Yield of ARCL Organics Ltd is 0.00 %.
What is the ROCE of ARCL Organics Ltd?
The ROCE of ARCL Organics Ltd is 20.4 %.
What is the ROE of ARCL Organics Ltd?
The ROE of ARCL Organics Ltd is 16.8 %.
What is the Face Value of ARCL Organics Ltd?
The Face Value of ARCL Organics Ltd is 10.0.